AI Due Diligence Innovation
AI based biopharma due diligence
AI technologies are emerging in all technology sectors. This whitepaper describes a new due diligence paradigm using a multi-factorial analysis of foundational science using agentic AI systems. This solution shifts due diligence from passive data review to an active, forensic search for unidentified evidence.
Bioprinting Innovation
Bioprinting Cartilage Grafts
Bioprinting is an emerging technology for the fabrication of patient-specific, anatomically complex tissues and organs. Patient's cells were embedded in the bioink and bioprinted into real size constructs. This research was published in Advanced Functional Materials Journal in 2015.
Nose made by bioprinters
3D printers are opening up new opportunities in medicine. Cartilage transplants using the body’s own cells were used to research translatability of bioprinting. This research was featured in ETH Zurich Globe magazine 2015.
https://ethz.ch/en/news-and-events/eth-news/news/2015/03/nose-made-by-bioprinters.html
Ears from the 3D printer
At ETH Zurich, human ears are being printed using real cartilage donor cells. The goal is to one day provide children with congenital deformities with new ears. Story featured in Swiss national TV (SRF).
Ohren aus dem 3D-Drucker
An der ETH Zürich werden menschliche Ohren mit echten Knorpel-Spenderzellen gedruckt. Das Ziel: Dereinst Kindern mit angeborenen Missbildungen neue Ohrmuscheln zu verschaffen
https://www.srf.ch/wissen/gesundheit/ohren-aus-dem-3d-drucker